Literature DB >> 29497819

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.

David N Louis1, Caterina Giannini2, David Capper3, Werner Paulus4, Dominique Figarella-Branger5, M Beatriz Lopes6, Tracy T Batchelor7, J Gregory Cairncross8, Martin van den Bent9, Wolfgang Wick10,11,12, Pieter Wesseling13,14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29497819     DOI： 10.1007/s00401-018-1826-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  97 in total

1.  High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.

Authors:  Kiyotaka Saito; Kiyotaka Yokogami; Kazunari Maekawa; Yuichiro Sato; Shinji Yamashita; Fumitaka Matsumoto; Asako Mizuguchi; Hideo Takeshima
Journal:  Hum Cell       Date:  2021-01-17       Impact factor: 4.174

Review 2.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

Review 3.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

4.  Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.

Authors:  Fausto J Rodriguez; Jacqueline A Brosnan-Cashman; Sariah J Allen; M Adelita Vizcaino; Caterina Giannini; Sandra Camelo-Piragua; Milad Webb; Marcus Matsushita; Nitin Wadhwani; Abeer Tabbarah; Dima Hamideh; Liqun Jiang; Liam Chen; Leonidas D Arvanitis; Hussein H Alnajar; John R Barber; Alicia Rodríguez-Velasco; Brent Orr; Christopher M Heaphy
Journal:  Brain Pathol       Date:  2018-10-17       Impact factor: 6.508

5.  Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.

Authors:  Kiyong Na; Hyun-Soo Kim; Hyo Sup Shim; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim
Journal:  J Neurooncol       Date:  2019-02-01       Impact factor: 4.130

6.  Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.

Authors:  Xiaorui Su; Ni Chen; Huaiqiang Sun; Yanhui Liu; Xibiao Yang; Weina Wang; Simin Zhang; Qiaoyue Tan; Jingkai Su; Qiyong Gong; Qiang Yue
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

7.  Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas.

Authors:  Cinthya J Zepeda-Mendoza; Rachael A Vaubel; Shabnam Zarei; Cristiane M Ida; Martin Matthews; Sara Acree; Aditya Raghunathan; Caterina Giannini; Robert B Jenkins
Journal:  Acta Neuropathol       Date:  2020-03-13       Impact factor: 17.088

Review 8.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

9.  Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma.

Authors:  Kaishi Satomi; Makoto Ohno; Yuko Matsushita; Masamichi Takahashi; Yasuji Miyakita; Yoshitaka Narita; Koichi Ichimura; Akihiko Yoshida
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

Review 10.  Pineal Gland Tumor Microenvironment.

Authors:  Joham Choque-Velasquez; Szymon Baluszek; Roberto Colasanti; Sajjad Muhammad; Juha Hernesniemi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.